Former KL2 Scholar Honored as Brilliant New Investigator
Feng (Vankee) Lin, PhD, RN, assistant professor of Nursing at the University of Rochester and past KL2 scholar, will receive the Brilliant New Investigator Award from the Council for the Advancement of Nursing Science (CANS) this fall. The award recognizes early stage scientists who show extraordinary potential to develop sustained programs of research that will have a significant impact on the science and practice of nursing and health care.
Lin received a KL2 Mentored Career Development Award from the University of Rochester Clinical and Translational Science Institute in 2013 to examine how computer-based brain fitness activities may slow cognitive and functional decline in older adults with mild cognitive impairment, a precursor to Alzheimer’s disease. Since, she has secured a $2 million National Institute of Nursing Research grant to continue this research, and a $421,000 grant from the National Institute on Aging to study fatigability among aging populations. She also recently received the University of Rochester’s Valerie and Frank Furth Fund Award to support her investigation of “supernormals”, older adults who have maintained their memory capacity substantially better than their peers.
Lin currently carries joint appointments as an assistant professor in nursing, the Department of Psychiatry and the Department of Brain and Cognitive Science. She is also director of the CogT Laboratory, which focuses on preventing cognitive decline and promotes successful cognitive aging.
The project described in this publication was supported by the University of Rochester CTSA award number KL2 TR000095 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The KL2 Mentored Career Development program provides 2 years of support for new investigators interested in a career in clinical or translational research. The program is designed to support the career development of those who wish to pursue research careers in multidisciplinary clinical and translational science.
Read more about the KL2 program, and check out a list of our current and past scholars.
Michael Hazard | 8/3/2016
